ProKidney to Host Virtual KOL Event to Discuss Current Treatment Landscape of Chronic Kidney Disease Caused by Diabetes and Data from Phase 2 RMCL-002 Clinical Trial on May 28, 2024

WINSTON-SALEM, N.C., May 21, 2024 -- ProKidney Corp. , a leading late clinical-stage cellular therapeutics company focused on chronic kidney disease , will host a virtual KOL event on Tuesday, May...

Related Keywords

Fresno ,California ,United States ,American ,Arnoldl Silva ,Ethan Holdaway ,University Of Arizona ,Translational Research ,Lifesci Advisors ,Company Class ,Prokidney Corp ,Icahn School Of Medicine At Mount Sinai ,European Renal Association ,Division Of Nephrology ,Nasdaq ,Biocon ,University Of California ,California State University ,Department Of Internal Medicine ,Exchange Commission ,American Society Of Nephrology ,Boise Kidney Hypertension Institute ,Globenewswire Inc ,Clinical Research ,Mount Sinai ,Renal Association ,Associate Chair ,Internal Medicine ,Precision Medicine Project ,Distinguished Researcher Award ,Home Hemodialysis ,Peritoneal Dialysis ,State University ,Clinical Assistant Professor ,Principal Investigator ,Regenerative Medicine Advanced Therapy ,Private Securities Litigation Reform Act ,Annual Report ,Quarterly Reports ,Sci Advisors ,